v3.26.1
Segment Information - Schedule of segment net loss and significant segment expenses (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting Information [Line Items]            
Research and Development Expense $ 18,048   $ 17,185   $ 38,919 $ 30,221
General and Administrative Expense 6,170   5,147   12,600 10,409
Total operating expenses 24,218   22,332   51,519 40,630
Net loss (22,285) $ (25,241) (19,984) $ (15,906) (47,526) (35,890)
Operating Segments [Member]            
Segment Reporting Information [Line Items]            
Non-employee-related general and administrative expenses 2,314   2,185   5,136 4,914
Other segment expenses1 [1] 2,364   649   3,835 730
Net loss 22,285   19,984   47,526 35,890
Operating Segments [Member] | Employee Related Expenses [Member]            
Segment Reporting Information [Line Items]            
Research and Development Expense 4,050   3,159   8,169 6,323
General and Administrative Expense 1,592   1,518   3,347 2,855
Operating Segments [Member] | Research and Pre-clinical Expenses [Member]            
Segment Reporting Information [Line Items]            
Research and Development Expense 1,905   1,737   3,483 3,738
Operating Segments [Member] | Clinical and Development Expenses [Member]            
Segment Reporting Information [Line Items]            
Research and Development Expense 8,461   5,692   18,125 10,096
Operating Segments [Member] | Non-ClinicalScienceExpenses[Member]            
Segment Reporting Information [Line Items]            
Research and Development Expense 596   1,197   910 1,903
Operating Segments [Member] | Chemistry, Manufacturing, and Control Expenses [Member]            
Segment Reporting Information [Line Items]            
Research and Development Expense $ 1,003   $ 3,847   $ 4,521 $ 5,331
[1] Other segment expenses include expenses not captured in the primary categories above, such as stock-based compensation, depreciation and amortization, interest income and interest expense.